Tokyo Metropolitan Hiroo Hospital is located in Shibuya, Tokyo, Japan. It has 426 beds and is run by the Tokyo Metropolitan Government. The hospital focuses on emergency and disaster medical care, cardiovascular diseases, cerebrovascular diseases, and care for residents of outlying islands near Tokyo.

There are 426 beds in Tokyo Metropolitan Hiroo Hospital.

During the past decade, Tokyo Metropolitan Hiroo Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tokyo Metropolitan Hiroo Hospital" are "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials) and "Tachycardia" (1 trials). Many other conditions were trialed in "Tokyo Metropolitan Hiroo Hospital" in a lesser frequency.

Most popular intervention types in "Tokyo Metropolitan Hiroo Hospital" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cypher stent" (1 trials), "PARADYM DR model 8550; PARADYM CRT model 8750; PARADYM RF DR model 9550; PARADYM RF CRT model 9750; PARADYM RF CRT SonR model 9770" (1 trials) and "TAXUS stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Metropolitan Hiroo Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo Metropolitan Hiroo Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tokyo Metropolitan Hiroo Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Metropolitan Hiroo Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".